• Return to Headlines

Sorrento Therape has the Lowest Current Ratio in the Biotechnology Industry (SRNE, ANTH, VTVT, INSY, TTOO)

By Amy Schwartz

Below are the three companies in the Biotechnology industry with the lowest current ratios. Current ratio is useful to get an idea of how quickly a company can repay its short-term liabilities with its short-term assets. The higher the current ratio, the more capable the company is of paying its obligations.

Sorrento Therape ranks lowest with a a current ratio of 0.4. Anthera Pharmace is next with a a current ratio of 0.7. Vtv Therapeuti-A ranks third lowest with a a current ratio of 0.8.

Insys Therapeuti follows with a a current ratio of 0.8, and T2 Biosystems rounds out the bottom five with a a current ratio of 0.9.

SmarTrend recommended that its subscribers protect gains by selling shares of T2 Biosystems on October 9th, 2018 by issuing a Downtrend alert when the shares were trading at $5.75. Since that call, shares of T2 Biosystems have fallen 24.2%. We are now looking for when a new Uptrend will commence and will alert SmarTrend subscribers in real time.

Keywords: lowest current ratio sorrento therape anthera pharmace vtv therapeuti-a insys therapeuti t2 biosystems

Ticker(s): SRNE ANTH VTVT INSY TTOO